1-1 of 1
Daniel Adelman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Dose-Escalation Study of the Novel Cell Cycle Active Agent SNS-595 in Advanced Leukemias.

Free
Jeffrey E. Lancet, MD, Judith E. Karp, MD, Nancy Havrilla, Ute Hoch, PhD, Jeffrey Silverman, PhD, Daniel Adelman, MD, Francis J. Giles, MD
Journal: Blood
Blood (2006) 108 (11): 1962.
https://doi.org/10.1182/blood.V108.11.1962.1962
Published: 2006